Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

35. Accelerating Diagnostic Innovation w/ David Walt - Professor @ Harvard / Core Faculty @ Wyss Institute

35. Accelerating Diagnostic Innovation w/ David Walt - Professor @ Harvard / Core Faculty @ Wyss Institute

FromBIOS


35. Accelerating Diagnostic Innovation w/ David Walt - Professor @ Harvard / Core Faculty @ Wyss Institute

FromBIOS

ratings:
Length:
44 minutes
Released:
Feb 4, 2022
Format:
Podcast episode

Description

David Walt is the Hansjörg Wyss Professor of Bioinspired Engineering @ Harvard Medical School, Professor of Pathology @ Harvard Medical School & Brigham and Women’s Hospital, Core Faculty Member of the Wyss Institute @ Harvard University, Associate Member @ the Broad Institute, Howard Hughes Medical Institute Professor, & is co-Director of the Mass General Brigham Center for COVID Innovation. Walt pioneered the use of microwell arrays for single-molecule detection and genetic measurements, which has revolutionized the process of genetic and proteomic analysis, enabling the cost of DNA sequencing and genotyping to plummet nearly a millionfold in the last decade. Walt is the Scientific Founder of Illumina, Quanterix, and has co-founded multiple other life sciences startups including Ultivue, Arbor Biotechnologies, Sherlock Biosciences, Vizgen, and Torus Biosciences. His lab develops new diagnostics tools and new biomarker assay technologies based on single molecule detection that can address unmet clinical needs in diagnostics.  The lab is focused on early detection of breast cancer, detection of active tuberculosis and other infectious diseases, and diagnosis of neurodegenerative diseases, His lab has also been deeply involved in developing new tools to understand and diagnose COVID-19. Walt’s lab also pursues fundamental research on single enzyme molecules to provide insight into enzyme mechanisms. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the 2021 Kabiller Prize in Nanoscience and Nanomedicine. He is a member of the U.S. National Academy of Engineering, the U.S. National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, a Fellow of the American Association for the Advancement of Science, a Fellow of the National Academy of Inventors, and is inducted in the US National Inventors Hall of Fame. Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license) 
Released:
Feb 4, 2022
Format:
Podcast episode

Titles in the series (63)

BIOS Podcast brings together cutting-edge insights from Life Science industry leaders at the forefront of innovation. Join us in hearing from Founders, Investors, Professors, & Pharma operating at the intersection of Technology & Biology. By Alix Ventures: Driving Patient Impact - Supporting early stage Life Science startups engineering biology to drive radical advances in human health. Learn more @ BIOS.community / Alix.vc __________________________________ Alix Ventures, by way of BIOS Community, is providing this content for general information purposes only. Reference to any specific product or entity does not constitute an endorsement nor recommendation by Alix Ventures, BIOS Community, or its affiliates. The views & opinions expressed by guests are their own & their appearance on the program does not imply an endorsement of them nor any entity they represent. Views & opinions expressed by Alix Ventures employees are those of the employees & do not necessarily reflect the view of Alix Ventures, BIOS Community, affiliates, nor its content sponsors.